FDA-approved semaglutide from Novo Nordisk undergoes rigorous manufacturing controls, batch testing, stability studies, and quality assurance processes mandated by the FDA
However, when combined with insulin or sulfonylureas, the risk of low blood sugar increases, which could potentially trigger headaches in some individuals
Other groups of people who have a higher risk include people over age 60, people on certain medications for diabetes, people with Crohns disease, celiac, ulcerative colitis and irritable bowel syndrome and women with a history of infertility or miscarriage
Lokesh Jangid Address G-104, Riico Industrial Area, Prahladpura, Tonk Road, Jaipur, Rajasthan, 302022, India Report incorrect details
10.1007/s11306-016-1094-6 16 BokulichN
A numerically lower MACE was observed with semaglutide, while tirzepatide demonstrated favorable heart failure profiles